Table 2. Univariate analysis of 5-year cause specific survival.
| 5-year CSS (95% CI) | Univariate analysis | ||
|---|---|---|---|
| Log rank | P value | ||
| Sex | 24.38 | <0.001 | |
| Male | 62.1% (61.9%-62.3%) | ||
| Female | 62.5% (62.3%-62.7%) | ||
| Age | 2697.73 | <0.001 | |
| <70 | 65.6% (65.4%-65.8%) | ||
| >69 | 58.7% (58.5%-58.9%) | ||
| Race/ethnicity | 985.98 | <0.001 | |
| Caucasian | 62.9% (62.8%-63.1%) | ||
| Chinese | 66.7% (65.7%-67.7%) | ||
| African American | 55.9% (55.4%-56.3%) | ||
| Married status | 3034.92 | <0.001 | |
| Single | 57.7% (57.3%-58.2%) | ||
| Separated or divorced | 59.6% (59.1%-60.0%) | ||
| Widowed | 56.6% (56.3%-56.9%) | ||
| Married | 65.4% (65.2%-65.5%) | ||
| Primary tumor | 674.08 | <0.001 | |
| Left colon | 64.0% (63.7%-64.2%) | ||
| Right colon | 61.6% (61.4%-61.8%) | ||
| Rectum | 60.3% (60.0%-60.6%) | ||
| AJCC 6th TNM stage | 84623.76 | <0.001 | |
| I | 90.9% (90.6%-91.2%) | ||
| II | 81.3% (80.9%-81.7%) | ||
| III | 66.8% (66.3%-67.3%) | ||
| IV | 12.2% (11.8%-12.6%) | ||
| Histology subtype | 2769.67 | <0.001 | |
| Signet ring cell | 30.4% (29%-31.9%) | ||
| Mucinous adenocarcinoma | 57.1% (56.6%-57.6%) | ||
| Other adenocarcinoma | 63.1% (63%-63.3%) | ||
| Grade | 13698.5 | <0.001 | |
| Well differentiated | 73.9% (73.5%-74.3%) | ||
| Moderately differentiated | 65.8% (65.6%-66%) | ||
| Poorly differentiated | 48.1% (47.8%-48.5%) | ||
| Undifferentiated | 45.9% (44.5%-47.4%) | ||
| Insurance status | 105.08 | <0.001 | |
| Uninsured | 57.8% (55.7%-59.9%) | ||
| Insured | 67.2% (66.8%-67.5%) | ||
| Time of diagnosis | 4835.37 | <0.001 | |
| 1973-1979 | 50.7% (50.2%-51.1%) | ||
| 1980-1989 | 57.3% (57.0%-57.7%) | ||
| 1990-1999 | 62.3% (62.0%-62.6%) | ||
| 2000-2012 | 65.9% (65.7%-66.1%) | ||
CSS: Cause specific survival
CI: Confidence interval
AJCC: American Joint Committee on Cancer
TNM: Tumor-Node-Metastasis